Glenmark Life Sciences Ltd
GLSGlenmark Life Sciences Ltd
GLS![](https://assets.tickertape.in/sector-icons/health_care.png)
![](https://assets.tickertape.in/sector-icons/smallcap.png)
![](https://assets.tickertape.in/sector-icons/moderate_risk.png)
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
27.58 | 5.77 | 2.24% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.93 | 6.39 | 0.52% |
Forecast & Ratings
Detailed Forecast from 6 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Glenmark Life Sciences Ltd is a manufacturer of pharmaceutical preparation. The Company was founded in June 2011 and is located in Solapur, India.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 0.25 | 886.86 | 1,549.30 | 1,885.98 | 2,137.91 | 2,190.18 | 2,295.26 | 2,309.07 | ||||||||
Raw Materials | 0.04 | 633.56 | 668.66 | 948.17 | 977.96 | 1,068.56 | 1,608.97 | 1,652.81 | ||||||||
Power & Fuel Cost | 0.00 | 57.81 | 76.75 | 74.19 | 100.92 | 115.60 | ||||||||||
Employee Cost | 0.15 | 106.28 | 142.28 | 149.13 | 168.72 | 180.18 | ||||||||||
Selling & Administrative Expenses | 0.00 | 44.20 | 42.05 | 48.50 | 48.64 | 65.99 | ||||||||||
Operating & Other expenses | 0.08 | -203.15 | 135.61 | 74.11 | 210.91 | 88.59 | ||||||||||
EBITDA | -0.02 | 248.16 | 483.95 | 591.88 | 630.76 | 671.26 | 686.29 | 656.26 | ||||||||
Depreciation/Amortization | 0.00 | 19.26 | 29.37 | 33.39 | 37.88 | 42.09 | 53.45 | 55.23 | ||||||||
PBIT | -0.02 | 228.90 | 454.58 | 558.49 | 592.88 | 629.17 | 632.84 | 601.03 | ||||||||
Interest & Other Items | 0.00 | 0.61 | 33.52 | 87.55 | 27.96 | 0.55 | 1.55 | 1.50 | ||||||||
PBT | -0.02 | 228.29 | 421.06 | 470.94 | 564.92 | 628.62 | 631.29 | 599.53 | ||||||||
Taxes & Other Items | 0.42 | 32.71 | 107.97 | 119.37 | 146.20 | 161.65 | 160.40 | 152.61 | ||||||||
Net Income | -0.44 | 195.58 | 313.09 | 351.57 | 418.72 | 466.97 | 470.89 | 446.92 | ||||||||
EPS | -8.00 | 36.10 | 29.04 | 32.61 | 36.36 | 38.11 | 38.43 | 36.48 | ||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 21.00 | 42.00 | 22.50 | 22.50 | ||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.58 | 1.10 | 0.59 | 0.62 |
Company Updates
Investor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Glenmark Life Sciences Ltd | 26.18 | 5.77 | 2.24% |
Sun Pharmaceutical Industries Ltd | 45.08 | 6.43 | 0.75% |
Cipla Ltd | 31.71 | 4.88 | 0.80% |
Torrent Pharmaceuticals Ltd | 70.18 | 16.95 | 0.82% |
Price Comparison
Compare GLS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Glenmark Life Sciences Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Plan Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.5285% | Percentage of the fund’s portfolio invested in the stock 1.58% | Change in the portfolio weight of the stock over the last 3 months 1.35% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/49 (+12) |
Union Small Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.1709% | Percentage of the fund’s portfolio invested in the stock 1.33% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 22/110 (+2) |
Union Flexi Cap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.1564% | Percentage of the fund’s portfolio invested in the stock 0.87% | Change in the portfolio weight of the stock over the last 3 months -0.03% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 71/92 (-15) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateOct 17, 2023
Dividend/Share
₹22.50
Ex DateEx Date
Oct 17, 2023
Cash Dividend
Ex DateEx DateMar 24, 2023
Dividend/Share
₹21.00
Ex DateEx Date
Mar 24, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Dividend/Share
₹10.50
Ex DateEx Date
Sep 15, 2022
Cash Dividend
Ex DateEx DateNov 22, 2021
Dividend/Share
₹10.50
Ex DateEx Date
Nov 22, 2021
HUL, Lux Industries shares gain despite market crash
![](https://pocket-image-cache.com/direct?url=http://img.etimg.com/thumb/msid-112282945,width-1200,height-630,imgsize-23852,overlay-etmarkets/photo.jpg)
Glenmark Life Sciences Ltd leads gainers in ‘A’ group
![](https://pocket-image-cache.com/direct?url=http://www.business-standard.com/assets/web-assets/images/Business_Standard_685x385.jpg)
Tamilnad Mercantile Bank Ltd, Marico Ltd, Rossari Biotech Ltd and Nestle India Ltd are among the other gainers in the BSE's 'A' group today, 05 August 2024.Glenmark Life Sciences Ltd soared 6.76% to Rs 939.3 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 23295 shares were traded on the counter so far as against the average daily volumes of 23721 shares in the past one month. Tamilnad Mercantile Bank Ltd spiked 3.68% to Rs 468.7. The stock was the second biggest gainer in 'A' group. On the BSE, 1.84 lakh shares were traded on the counter so far as against the average daily volumes of 11409 shares in the past one month. Marico Ltd surged 1.94% to Rs 674.8. The stock was the third biggest gainer in 'A' group. On the BSE, 96840 shares were traded on the counter so far as against the average daily volumes of 1.4 lakh shares in the past one month. Rossari Biotech Ltd gained 1.07% to Rs 918.7. The stock was the fourth biggest gainer in 'A' group. On the BSE, 89730 shares were traded on the counter so far as against the average daily volumes of 19439 shares in the past one month. Nestle India Ltd advanced 0.68% to Rs 2511.3. The stock was the fifth biggest gainer in 'A' group. On the BSE, 16742 shares were traded on the counter so far as against the average daily volumes of 51971 shares in the past one month. Powered by Capital Market - Live
Stock that will see action today: July 29, 2024
![](https://pocket-image-cache.com/direct?url=http://bl-i.thgim.com/public/incoming/vic81f/article68457633.ece/alternates/LANDSCAPE_1200/PO05_Stock_data.jpg)
Glenmark Life drops after Q1 PAT slides 18% YoY to Rs 111 cr
![](https://pocket-image-cache.com/direct?url=http://www.business-standard.com/assets/web-assets/images/Business_Standard_685x385.jpg)
Glenmark Life Sciences standalone net profit declines 17.70% in the June 2024 quarter
![](https://pocket-image-cache.com/direct?url=http://www.business-standard.com/assets/web-assets/images/Business_Standard_685x385.jpg)
Net profit of Glenmark Life Sciences declined 17.70% to Rs 111.48 crore in the quarter ended June 2024 as against Rs 135.45 crore during the previous quarter ended June 2023. Sales rose 1.76% to Rs 588.62 crore in the quarter ended June 2024 as against Rs 578.45 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales588.62578.45 2 OPM %27.1033.39 - PBDT164.63194.62 -15 PBT150.24182.01 -17 NP111.48135.45 -18 Powered by Capital Market - Live
Q1 Results Today: Adani Green, DLF, Canara Bank Among 75+ Firms To Declare Earnings
![](https://pocket-image-cache.com/direct?url=http://media.assettype.com/bloombergquint%2F2024-06%2F1b816c62-6147-49ac-9f60-0996b59236eb%2FStock_graph_in_seen_on_a_monitor___Source_pxhere_.jpg?rect=0%2C0%2C1200%2C630&w=1200&auto=format%2Ccompress&ogImage=true)
Stock alert: Axis Bank, Larsen & Toubro, SBI Life Insurance Company, J K Paper, Bikaji Foods, Oracle Financal Services Software
![](https://pocket-image-cache.com/direct?url=http://www.business-standard.com/assets/web-assets/images/Business_Standard_685x385.jpg)
Q1 results today: Nestle, Tech Mahindra among 76 companies to announce earnings on Thursday
![](https://pocket-image-cache.com/direct?url=http://img.etimg.com/thumb/msid-112001590,width-1200,height-630,imgsize-18446,overlay-etmarkets/photo.jpg)
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 20.95%, vs industry avg of 9.21%
Increasing Market Share
Over the last 5 years, market share increased from 0.39% to 0.61%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 19.21%, vs industry avg of 15.17%